Back

prof. dr. ir. J.J.W. Lagendijk

prof. dr. ir. J.J.W. Lagendijk

Professor Emeritus

Show full profile

Research Output (338)

Fast and accurate deformable contour propagation for intra-fraction adaptive magnetic resonance-guided prostate radiotherapy

Willigenburg Thomas, Zachiu Cornel, Lagendijk Jan J W, van der Voort van Zyp Jochem R N, de Boer Hans C J, Raaymakers Bas W Jan 2022, In: Physics and Imaging in Radiation Oncology. 21 , p. 62-65 4 p.

Conventional radical versus focal treatment for localised prostate cancer:a propensity score weighted comparison of 6-year tumour control

van Son Marieke J., Peters Max, Reddy Deepika, Shah Taimur T., Hosking-Jervis Feargus, Robinson Stephen, Lagendijk Jan J.W., Mangar Stephen, Dudderidge Tim, McCracken Stuart, Hindley Richard G., Emara Amr, Nigam Raj, Persad Raj, Virdi Jaspal, Lewi Henry, Moore Caroline, Orczyk Clement, Emberton Mark, Arya Manit, Ahmed Hashim U., van der Voort van Zyp Jochem R.N., Winkler Matt, Falconer Alison Dec 2021, In: Prostate cancer and prostatic diseases. 24 , p. 1120-1128 9 p.

Minimizing the need for coil attenuation correction in integrated PET/MRI at 1.5 T using low-density MR-linac receive arrays

Zijlema Stefan Emiel, Branderhorst Woutjan, Bastiaannet Remco, Tijssen Rob H N, Lagendijk Jan J W, Van den Berg Cornelis A T 27 Sep 2021, In: Physics in medicine and biology. 66 , p. 1-12 12 p.

Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac

De D. M. Muinck Keizer, Willigenburg T., Van J. R. N. der Voort van Zyp, Raaymakers B. W., Lagendijk J. J. W., De J. C. J. Boer Sep 2021, In: Radiotherapy and Oncology. 162 , p. 162-169 8 p.

Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer

Willigenburg Thomas, van Son Marieke J, van de Pol Sandrine M G, Eppinga Wietse S C, Lagendijk Jan J W, de Boer Hans C J, Moerland Marinus A, van der Voort van Zyp Jochem R N, Peters Max Sep 2021, In: Clinical and translational radiation oncology. 30 , p. 7-14 8 p.

An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients

Boekhoff Mick, Defize Ingmar, Borggreve Alicia, van Hillegersberg Richard, Kotte Alexis, Lagendijk Jan, van Lier Astrid, Ruurda Jelle, Takahashi Noriyoshi, Mook Stella, Meijer Gert Sep 2021, In: Radiotherapy and Oncology. 162 , p. 76-84 9 p.

Targeted biopsies are redundant in mp-MRI and PSMA- PET proven radiorecurrent prostate cancer

Peters M., van Son M., Rasing M., Lagendijk J., Moerland M., van de Pol S., Eppinga W., Jonges T., Wessels F., de Keizer B., Noteboom J., van Zyp J. van der Voort Aug 2021, In: Radiotherapy and Oncology. 161 , p. S1124-S1125

Fast deformable contour propagation for intra-fraction adaptive MR-guided prostate radiotherapy

Willigenburg T., Zachiu C., Lagendijk J., de Boer H., van Zyp J. van der Voort, Raaymakers B. Aug 2021, In: Radiotherapy and Oncology. 161 , p. S174-S175

On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy

de Muinck Keizer Daan M., van der Voort van Zyp Jochem R.N., de Groot-van Breugel Eline N., Raaymakers Bas W., Lagendijk Jan J.W., de Boer Hans C.J. Jul 2021, In: Physics and Imaging in Radiation Oncology. 19 , p. 90-95 6 p.

MR compatibility, safety and accuracy of the redesigned UMC Utrecht single needle implant device

Moerland M. A., Van Schelven L. J., Van Lier A., Boskovic E., Peters M., Van Son M. J., Van Der Voort Van Zyp J. R.N., Lagendijk J. J.W. 21 Jun 2021, In: Physics in medicine and biology. 66 11 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not